These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6354924)

  • 1. Characteristics of live vaccines in relation to delayed-type hypersensitivity and protective immunity in murine experimental salmonellosis.
    Udhayakumar V; Muthukkaruppan V
    Immunol Lett; 1983 Jun; 6(6):299-302. PubMed ID: 6354924
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of immunization with a rough strain of Salmonella enteritidis on the fate of Salmonella typhimurium in mice.
    Davies R; Kotlarski I
    Aust J Exp Biol Med Sci; 1974 Oct; 52(5):779-89. PubMed ID: 4280901
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of acquired resistance in mouse typhoid.
    Chander R; Lewis NF
    Microbiol Immunol; 1987; 31(3):223-30. PubMed ID: 3302624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice.
    Izhar M; DeSilva L; Joysey HS; Hormaeche CE
    Infect Immun; 1990 Jul; 58(7):2258-61. PubMed ID: 2194967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological study of protective immunity against murine salmonellosis induced by killed vaccine.
    Nakoneczna I; Hsu HS
    Infect Immun; 1983 Jan; 39(1):423-30. PubMed ID: 6337103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines.
    Muotiala A; Hovi M; Mäkelä PH
    Microb Pathog; 1989 Jan; 6(1):51-60. PubMed ID: 2659920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.
    Denich K; Börlin P; O'Hanley PD; Howard M; Heath AW
    Infect Immun; 1993 Nov; 61(11):4818-27. PubMed ID: 8406883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium.
    Germanier R
    Infect Immun; 1972 May; 5(5):792-7. PubMed ID: 4564882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of tumor necrosis factor in immunity to Salmonella infection.
    Tite JP; Dougan G; Chatfield SN
    J Immunol; 1991 Nov; 147(9):3161-4. PubMed ID: 1919009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Salmonella typhimurium mutant unable to utilize fatty acids and citrate is avirulent and immunogenic in mice.
    Utley M; Franklin DP; Krogfelt KA; Laux DC; Cohen PS
    FEMS Microbiol Lett; 1998 Jun; 163(2):129-34. PubMed ID: 9673014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and duration of protection against salmonellosis in mice and sheep immunised with live aromatic-dependent Salmonella typhimurium.
    Mukkur TK; Walker KH
    Res Vet Sci; 1992 Mar; 52(2):147-53. PubMed ID: 1533950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic studies of prevention of experimental salmonellosis (2). Distribution of SPA producing strains of S. typhimurium and correlation of protective immunity between SPA and killed vaccine (author's transl)].
    Sugihara H; Tanaka T; Kamiya K
    Kansenshogaku Zasshi; 1980 Jun; 54(6):299-305. PubMed ID: 6778935
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.
    Udhayakumar V; Muthukkaruppan VR
    Infect Immun; 1987 Mar; 55(3):816-21. PubMed ID: 3546142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of vaccines against Salmonella typhimurium infection.
    Severtsova MK; Stanislavsky ES; El'-Bashir AM; Zaidner IG
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):318-25. PubMed ID: 393775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination of pigeons against Salmonella infections].
    Grund S; Selbitz HJ; Kutzer P; Springer S; Eichberg J
    Berl Munch Tierarztl Wochenschr; 1997 May; 110(5):171-5. PubMed ID: 9290038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.
    Galán JE; Curtiss R
    Microb Pathog; 1989 Jun; 6(6):433-43. PubMed ID: 2671582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
    Nickol AD; Bonventre PF
    J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.
    Kita E; Emoto M; Yasui K; Yasui K; Katsui N; Nishi K; Kashiba S
    Immunology; 1986 Mar; 57(3):431-5. PubMed ID: 3514442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.
    Benjamin WH; Hall P; Briles DE
    Microb Pathog; 1991 Oct; 11(4):289-95. PubMed ID: 1813780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.